Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathology of malignant lymphomas.

P G Isaacson1

  • 1Department of Histopathology, University College and Middlesex School of Medicine, London, UK.

Current Opinion in Oncology
|October 1, 1992
PubMed
Summary

Advancements in molecular genetics and immunohistochemistry are revolutionizing malignant lymphoma classification. These techniques offer deeper biological insights than morphology alone, impacting the understanding of B- and T-cell lymphomas.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism.

Leukemia·2010
Same author

Continual monitoring of intraepithelial lymphocyte immunophenotype and clonality is more important than snapshot analysis in the surveillance of refractory coeliac disease.

Gut·2009
Same author

A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma.

Leukemia·2009
Same author

A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands.

The Journal of pathology·2008
Same author

The phenotype of intraepithelial lymphocytes in Taiwanese enteropathy-associated T-cell lymphoma is distinct from that of the West.

Histopathology·2008
Same author

Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders.

Journal of clinical pathology·2007

Area of Science:

  • Pathology
  • Oncology
  • Molecular Biology

Background:

  • Malignant lymphoma classification relies heavily on morphology, but this approach has limitations in understanding tumor biology.
  • Developing a clinically relevant and reproducible classification requires integrating molecular and genetic data.

Purpose of the Study:

  • To explore how advancements in immunohistochemistry and molecular genetics are enhancing the classification of malignant lymphomas.
  • To investigate the role of genetic rearrangements and Epstein-Barr virus in lymphoma pathogenesis.

Main Methods:

  • Utilizing immunohistochemistry to analyze cell markers.
  • Employing molecular genetics to identify oncogenetic rearrangements.
  • Developing in situ molecular hybridization techniques for pathogen identification.

Main Results:

  • Significant progress has been made in understanding B- and T-cell lymphomas through the correlation of genetic rearrangements with morphology.
  • Epstein-Barr virus is implicated in the pathogenesis of lymphomas, particularly in immunodeficient individuals.
  • The distinction between Hodgkin's disease and non-Hodgkin's lymphoma is becoming less clear due to new molecular findings.

Conclusions:

  • Morphology alone is insufficient for a comprehensive understanding and classification of malignant lymphomas.
  • Immunohistochemistry and molecular genetics are crucial for advancing lymphoma classification and understanding its biology.
  • Further research is needed to fully elucidate the implications of these new findings for clinical practice.

Related Experiment Videos